Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1075 of 1863 entries
View as:

Magnetic Resonance Imaging and Spectroscopy of the Prostate

Phase: N/A Priority: Normal
NCT ID: NCT00590993 Org: User:
Start: 12/31/00 End: 02/28/13 Due: 02/28/14

A Study of the Effect of Blood Stem Cell Transplant After Chemotherapy Alone in Patients With Fanconi Anemia

Phase: N/A Priority: Normal
NCT ID: NCT03600909 Org: User:
Start: 05/15/18 End: 04/09/21 Due: 04/09/22

Measuring Real Time Decision-Making About Ultraviolet Radiation (UVR) Protection

Phase: N/A Priority: Normal
NCT ID: NCT01004952 Org: User:
Start: 10/27/09 End: 09/06/24 Due: 09/06/25

Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission

Phase: N/A Priority: Normal
NCT ID: NCT00002534 Org: User:
Start: 05/31/93 End: 04/30/03 Due: 04/30/04

CT7, MAGE-A3, and WT1 mRNA-electroporated Autologous Langerhans-type Dendritic Cells as Consolidation for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT01995708 Org: User:
Start: 01/31/14 End: 06/20/22 Due: 06/20/23

A Study of Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone

Phase: N/A Priority: Normal
NCT ID: NCT03909152 Org: User:
Start: 05/02/19 End: 09/03/24 Due: 09/03/25

Use of an Interactive 3D Tool During Consultation for Breast Reconstruction Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05025020 Org: User:
Start: 08/23/21 End: 08/31/25 Due: 08/31/26

Lung Cancer Informational Study (LCIS)

Phase: N/A Priority: Normal
NCT ID: NCT00579215 Org: User:
Start: 11/30/06 End: 03/31/09 Due: 03/31/10

Phase II Trial of Pembrolizumab With Trastuzumab and Chemotherapy in Advanced HER2 Positive Esophagogastric (EG) Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02954536 Org: User:
Start: 11/03/16 End: 03/14/23 Due: 03/14/24

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00008359 Org: User:
Start: 08/31/00 End: - Due: -

Newer Breast MRI Sequences for the Evaluation of Breast Cancer -FIESTA, Vibrant-DE and IDEAL: Feasibility Evaluation

Phase: N/A Priority: Normal
NCT ID: NCT00579800 Org: User:
Start: 07/31/07 End: 05/31/16 Due: 05/31/17

A Study to Determine if Mesh Placement During Bladder Surgery Can Reduce the Chances of Developing a Hernia

Phase: N/A Priority: Normal
NCT ID: NCT02908061 Org: User:
Start: 08/31/16 End: 08/31/25 Due: 08/31/26

A Study of Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04671901 Org: User:
Start: 12/10/20 End: 03/29/23 Due: 03/29/24

A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management

Phase: N/A Priority: Normal
NCT ID: NCT03248310 Org: User:
Start: 08/09/17 End: 08/31/25 Due: 08/31/26

A Study of XmAb23104 in People With Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT05879185 Org: User:
Start: 04/06/23 End: 07/19/24 Due: 07/19/25

Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01312857 Org: User:
Start: 03/07/11 End: 07/15/24 Due: 07/15/25

Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00425802 Org: User:
Start: 11/28/06 End: 10/28/16 Due: 10/28/17

Study of BMS-986205 and Nivolumab in Endometrial Cancer or Endometrial Carcinosarcoma That Has Not Responded to Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04106414 Org: User:
Start: 09/24/19 End: 09/30/25 Due: 09/30/26

Investigating the Impact of Proactive Palliative Care

Phase: N/A Priority: Normal
NCT ID: NCT03667378 Org: User:
Start: 09/07/18 End: 09/30/25 Due: 09/30/26

Gene Expression Following Short Term Exposure to Neoadjuvant Endocrine Therapy in Invasive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00588003 Org: User:
Start: 03/31/04 End: 11/30/09 Due: 11/30/10

Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies

Phase: N/A Priority: Normal
NCT ID: NCT01877070 Org: User:
Start: 06/30/13 End: 06/30/26 Due: 06/30/27

Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT03473795 Org: User:
Start: 03/16/18 End: 03/31/26 Due: 03/31/27

Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT01182168 Org: User:
Start: 08/31/10 End: 03/31/16 Due: 03/31/17

Phase II Study of Ramucirumab With Chemotherapy in Patients With Metastatic Gastroesophageal Junction and Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02726399 Org: User:
Start: 03/18/16 End: 02/26/19 Due: 02/26/20

Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

Phase: N/A Priority: Normal
NCT ID: NCT03587844 Org: User:
Start: 07/03/18 End: 07/31/26 Due: 07/31/27